Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

JP: HIV is difficult to cure because one part of the virus' life cycle is to integrate its own DNA into the human DNA of the cell it is infecting. These cells are very long-lived and can lie ...

Furthermore, the mechanisms of inhibition all coincide with different stages in the HIV life cycle (Figure 1). When these processes (also called targets) are inhibited there is a corresponding upturn ...

Reports have appeared recently on agents that are active against several new targets in the HIV life cycle. These are: Rev inhibitors Zinc finger inhibitors Rev is a regulatory protein which permits ...

Corvus Pharmaceuticals Inc (NASDAQ: CRVS) announced new data demonstrating the potential of CPI-818, an ITK inhibitor, to reduce the need for chronic human immunodeficiency virus (HIV) therapy.

More than 1.2 million people across the U.S. have HIV with over 30,000 new cases diagnosed every year. There is no cure for HIV, but several treatments are available that can allow patients to ...

Like most busy mums, Mary's life is filled with packed lunches, homework supervision and after-school activities. She successfully juggles being a wife and rearing four children, ranging in age ...

The HIV proteins Tat, Rev and Nef, which are expressed early after infection, trigger key steps in the viral life cycle and optimize the intracellular milieu of the host cell for viral replication 14.

The Department of Health and Human Services building is seen in Washington on April 5, 2009. President Joe Biden’s administration has approved a new rule allowing organ transplants from HIV ...